Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

AIM ImmunoTech Has Been Granted European Patent Number EP4096675 Titled "COMPOSITIONS FOR TREATING LONG COVID"

Author: Benzinga Newsdesk | September 22, 2025 02:58pm

https://register.epo.org/application?number=EP21818146

Posted In: AIM

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist